Ask any trader, what is the largest problem with trading micro-cap stocks? They will tell you that the largest problem is being caught at the tail end holding the bag!

What is the foremost problem with receiving picks from the best newsletters? Emails are unreliable and never show up on time. We are solving both of these problems for you today.

Our members will get Pre-Promotion VIP Early Alerts from the most effective newsletters in the industry and the best part is they are delivered in real time via our PRIVATE TWITTER FEED: https://twitter.com/ALLVIPALERTS

We pay for Pre-Promotion, VIP and early alert services so you don't have to. Get the pre-promo information in one spot.

Do NOT Hesitate. We are offering this amazing opportunity FREE for 3 months to the first 500 followers.

No Credit     Card     No Spam     No Obligation     No Emails

We are focusing on multi-day longer campaigns to maximize the potential for our (ALLVIP) members.

This is a no brainer. We are paying thousands in VIP memberships to bring you the best picks in real time from the top newsletters in the industry. Join Now! Use the link above to become one the first followers to ALLVIPALERTS.

Be ready for what should be our biggest alert of the year. New public company with tiny float. Looking for monster triple digit gains.

Watch list for the Most Traded Stocks in the OTC Market. This is not an alert and we were not compensated for the following watch list.

Cellceutix Corp. (OTCBB: CTIX) has six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

The company is submitting a request to the Food and Drug Administration to conduct a pre-Investigational New Drug (IND) meeting to discuss development of a topical defensin-mimetic compound for the indication of induction of remission of ulcerative proctitis and ulcerative proctosigmoiditis. The current value of the company and its future prosperity are widely disputed by followers of the company’s fortunes and investors should investigate the pros and cons.

Electronic Cigarettes International Group, Inc. (OTCQB: ECIG) operates ZaZZZ, a consumer operated marijuana vending machine for dispensing of cannabis-based medicines. It also offers Jurassic Water for cannabis plants; truth lighting, a LED lighting solution; and OG tea nutrients, a specialty fertilizer product.

On February 4, 2015, ECIG entered into a securities purchase agreement with an accredited investor where the Company agreed to issue and the investor agreed to purchase, 5% Original Issue Discount Convertible Promissory Notes. ECIG issued to the investor $263,157.89 principal amount of 10% Convertible Notes for gross proceeds to the Company of $250,000.

Go Pro, Inc. (NASDAQ: GPRO) offers the HERO line of cameras; premium accessories, including battery BacPac, Wi-Fi remote, and equipment-based mounts, such as helmet, handlebar, roll bar, and tripod mounts that allow for the capture content while engaged in a range of activities, as well as mounts on their bodies consisting of wrist housings, chest harnesses, and head straps.

GPRO has reported financial results for the 4th quarter and fiscal year ending 12-31-14. The results show significant growth in both periods though the earning for the 2014 4th quarter fell short of analysts’ estimates. 

Vapor Group, Inc. (OTCBB: VPOR) designs, develops, manufactures and markets e-cigarette brands. Its products are marketed under the Vapor Group, Total Vapor, Vapor 123, and Vapor Products brands. The company offers e-liquids, which may or may not contain nicotine. It also offers a range of products with unique e-liquid flavors.

The company has increased its authorized share volume from 2.5 billion to 3.5 billion shares. The company, in a letter to shareholders, explains the need for additional shares is related to debt conversion.

ALLVIPALERTS employees are not registered as an Investment Adviser in any jurisdiction whatsoever. This press release is for informational purposes only and is not intended to be a recommendation to buy or sell securities in any of the companies listed here.

Source: ALLVIPALERTS

 
 

Innovation Pharmaceuticals (PK) (USOTC:IPIX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Innovation Pharmaceuticals (PK) Charts.
Innovation Pharmaceuticals (PK) (USOTC:IPIX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Innovation Pharmaceuticals (PK) Charts.